Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Do some real DD before you invest. There are many biotech's with real treatments for pancreatic cancer in mid to late stage trials. PMCB has been promoting its 20 year old cancer treatment that no real biotech was interested in for 5+ years. The company is run buy a shady former lawyer turned penny stock CEO with no prior biotech experience and his equally shady buddy a CPO. Listen to the last conference call where it was disclosed that complete failure is all that has been accomplished. These shady characters have sucked tens of millions of $$ in compensation out of this company in the past five years while doubling the share count and producing ZERO results.
There are real companies out their trying to cure cancer and diabetes. PMCB is not one of those companies. Five years of paying crooked management MILLIONS and MILLIONS Of $$ and no accomplishments other then the same PR's over and over.
Its the same SCAM as it has alway's been. PMCB has been issuing PR's for over five years about cell banks and clinical trials. To date not one speck of evidence that CIAB is good for anything. PMCB is in existence to pay its crooked management $MILLIONS
A shady company with a $55 million market cap (what a joke) that people think is a bargain because the PPS is .05. Truth is that its run by really shady people who have accomplished nothing but paying themselves $$MILLIONS and releasing fairy tale PR's about a product that no one wanted because it is a silly gimmick that has no real chance of curing anything. YES ITS A SCAM
Friday Scam Alert. PMCB and their shady management spent 3 years issuing PR after PR about their relationship with TD2 and Dr. Von Hoff. In Shady Kenny's CC which was never followed with a written PR it was revealed that TD2 will no longer be associated with PMCB. The link below was from a PR after the pre-ind and describes how important having a CRO involved long before a ind or trial begins. Shady Kenny suggested that TD2 was not capable of running a P3 trial. Yet TD2 appeared with Kenny at ASCO and gave the interview below. Next i am sure will be the PR that they have chosen CRO XX and because they need to be brought up to speed it will take time and shareholders should be patient. TRUTH IS THAT THIS COMPANY IS A SCAM AND ALWAYS HAS BEEN. DO YOUR DD !! That is all .....
http://pharmacyte.com/pharmacyte-biotech-ceo-addresses-ind-submission-questions/
Daily SCAM ALERT. Below are the headlines of all of the PR's this company has issued over 4 years claiming cells for trials are being prepared.
Sept. 17, 2013
Nuvilex Contracts With Inno Biologics, an FDA-Compliant Provider, for Initial Generation of Cloned Cells for Future Phase 3 Clinical Trials
Nov 4, 2013
Nuvilex Announces Cloning of Cells for Future Phase 3 Clinical Trials Initiated by Inno Biologics
Dec. 19, 2013
Nuvilex’s Provides Progress Update on Cell Cloning Being Performed by Inno Biologics
April 10, 2014
Nuvilex Engages ViruSure to Establish Cell Banks for Phase 2b Clinical
Trials in Pancreatic Cancer
28 NOV 17
PharmaCyte Biotech Announces Successful Completion of Cell Testing for Production of Master Cell Bank
Scam Alert! Every PR this company releases has been released before by them.
SILVER SPRING, MD, March 27, 2015 (GLOBE NEWSWIRE) – PharmaCyte Biotech, Inc. (OTCQB: PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that the genetically modified cells that are required for its three planned clinical trials have been fully tested and are in the process of being propagated to produce all of the cells necessary for the clinical trials.
The cells being produced came from a fully characterized single-cell clone of the cells that were used in the previous clinical trials in pancreatic cancer. These cells are being grown under conditions that comply with current Good Manufacturing Practices (cGMP) standards.
SILVER SPRING, Md., April 10, 2014 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, reported today that it has signed a Master Services Agreement with ViruSure GmbH, located in Vienna, Austria, to develop and maintain Master, Working and End of Production Cell Banks. These cell banks are necessary steps in the production of the cells to be encapsulated using the Cell-in-a-Box(R) technology for PharmaCyte Biotech’s Phase 2b clinical trials in advanced, inoperable pancreatic cancer to be conducted in Australia.
“ViruSure has previous experience in handling the exact cell line that will be used in our Phase 2b clinical trials, which was a major factor in PharmaCyte Biotech selecting ViruSure for this important step in our preparations for these trials,” said Kenneth L. Waggoner, CEO and President of PharmaCyte Biotech. “This decision was further supported by our on-site inspection of the ViruSure facilities and the excellent historical relationships between ViruSure’s key personnel with our partners at Austrianova. ViruSure has years of experience in producing and maintaining cell banks and is an industry leader in this arena.”
“We are delighted to be partnering with PharmaCyte Biotech on such an important project and in helping to bring this much needed therapy for such a devastating disease as pancreatic cancer to the clinic,” stated Andy Bailey, CEO and co-founder of ViruSure.
Its funny to watch people buying this scam at .058 because a cell was tested by someone. But its really disgusting to watch this scumbag KW issue no news PR's to pump the PPS up so he can sell shares to people yet no PR's are ever issued to disclose all of his failures. A typical day in penny land stock. A week from now all of the buyers today will be crying about the low PPS.
One day jump. A traders dream but not so good for longs ho hold their shares or something that never happens. Yes it is a scam and dopey PR's like testing a cell just validates that.
Good day to get out on a no news PR. They tested a cell and like usual penny stock buyers overreact really quite amusing to watch.
WOW they tested a cell amazing after only 5 years. Clinical trials can only be 20 years away. LOL what a scam.
Hilarious that some were spreading lies about partnerships and buyouts just a month ago and now we all know from the conference call that not only is no one interested in investing in PMCB but CIAB doesn't work for anything. Just a stock selling scam everyone!!
If you look back through some's history this reoccurring "sudden run up" and kaboom hype it has been going on for years. Most likely those who bought in the .30's and .20's hoping to hype it back to those levels so the can escape this train wreck.
A lawyer a CPA and a washed up doctor. No its not the start of a joke but it is a joke of a company.
LOL Three business models and 20 years of nothing but paying themselves $MILLIONS. Their not building a ship they are building private jets for themselves.
Its been a lot longer then 5 years now hasn't been. And yes it has been a scam for 20 years. Name one thing this company has ever accomplished.
In the past 4 fiscal years since Shady Kenny has been CEO this company has lost over $50,000,000 and what have they produced other then making several employees and former employees millionaires? NOTHING but excuses and failures. Due your due diligence. Read the past hype press releases on the company website promising clinical trials in 2014,2015,2016 and 2017 yet management has grossly increased their salary every year. Take note that not one full time employee has any medical background in fact every medical person associated with PMCB (consultant) has a full time plus job of there own not related to PMCB. Listen to the embarrassing conference call the CEO gave just two weeks ago admiting that everything they are involved in has failed or been a comedy of mismanagement. Take a look at the share count of 1,000,000,000 an increase of 100% since Shady Kenny has become CEO. IMHO PMCB is in business to sell shares and pay its useless employees. IMHO.
Alert. PMCB is a stock selling scam that has never produced anything in its 20 year history except making it Shady Management millionaires. Please do you due diligence before purchasing. Read the bogus claims of clinical trials starting in 2014,2015,2016 and 2017 all on the PMCB site under news. Listen to the CEO conference call from a few weeks ago where he had to admit that all of the treatments using CIAB have failed This companies only purpose is to sell shares and use that capital to pay its useless management. IMHO
Selling the same BS over and over. Year after year while the management pockets $MILLIONS.
SILVER SPRING, MD–(Marketwired – Nov 4, 2013) – PharmaCyte Biotech, Inc. (OTCQB: NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that cloning of the cancer-drug-activating cells required for PharmaCyte Biotech’s future Phase 3 clinical trials has begun at Inno Biologics in its cGMP-compliant facilities.
Following receipt by Inno Biologics of four vials of frozen cells capable of converting the well-known anticancer prodrug ifosfamide into its active cancer-killing form, one of the vials was thawed and the cells grown in culture. The cells, which were previously grown by ViruSure in Vienna, were successfully thawed, and approximately 97% of the cells were found to be viable. The contents of the vial were tested and found to be free of the “adventitious agents” bacteria, fungi, and mycoplasma.
The cloning process consists of growing cells in multiple microplates to produce a large number of discrete clones. “State-of-the-art” technology is then used in the cloning isolation process. After additional rigorous biochemical testing, those clones determined to be the “best” for PharmaCyte Biotech’s oncological purposes will be selected and additional testing will be done. Finally, the best clones will be propagated to obtain large numbers of cells required for the late-phase clinical trials of PharmaCyte Biotech.
PharmaCyte Biotech’s President and CEO, Dr. Robert F. Ryan, stated, “This is a critical juncture on the path to our planned late stage clinical trials. The important steps have and are being carefully planned and timed so as to bring us forward as quickly as possible for our planned pancreatic cancer clinical trials. The high level of viability seen on initial examination by Inno Biologics shows that the cells were grown and stored well by ViruSure prior to thawing. We are confident the companies we have chosen to take care of each of the activities are both competent and well equipped to complete the work.
Yes folks PMCB is a scam and its been going on for a long time.
SILVER SPRING, MD–(Marketwired – Sep 10, 2013) – PharmaCyte Biotech, Inc. (OTCQB: NVLX) (Company), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today it has contracted Fisher BioServices, Inc. for the long-term storage of cells that will be required for its future Phase 3 and other cancer clinical trials.
In order to ensure the safety and availability of cells to be used for its clinical trials, the Company has engaged Fisher BioServices located in Rockville, MD, USA, near PharmaCyte Biotech’s Silver Spring, MD, headquarters. Fisher BioServices, a part of Thermo Fisher BioScientific, Inc., an international company traded on the New York Stock Exchange with annual revenues of $13 billion and approximately 39,000 employees, is one of the leading companies in critical biological material management and cell and tissue storage with facilities around the world. This cell storage company adheres to Good Tissue Practice and Good Manufacturing Practice guidelines. Fisher BioServices currently stores more than 170 million biospecimens, including cells and tissues.
The Fisher BioServices facility, located in Rockville, MD, will be used as one of several cell storage sites around the world holding the PharmaCyte Biotech cancer treatment cells. Multi-site storage of our critically important cells is Standard Operating Procedure for companies, such as PharmaCyte Biotech, that are engaged in the use of cells for therapeutic purposes.
The cells to be stored in the Fisher BioServices facility both here and abroad are the same cells as those used in the Company’s past clinical trials for advanced, inoperable pancreatic cancer. These cells have the ability to activate the well-known anticancer drug ifosfamide. They will be maintained in the facility and can be propagated in the event of a loss in the system somewhere else to obtain cells for encapsulation as needed for clinical trials, including the Company’s pancreatic cancer treatment.
Dr. Robert F. Ryan, PharmaCyte Biotech’s President and CEO, commented, “We are glad to be able to engage a leading cell storage company as Fisher BioServices and have them take care of our major long-term cell storage needs. We have designed our storage plans with an intention that as we progress with our preparations, additional cells will be placed there as they are made for future clinical trials. This is a necessary and important step in the Company’s efforts toward carrying out our late-stage clinical trials in patients with advanced, inoperable pancreatic cancer.”
About PharmaCyte Biotech:
PharmaCyte Biotech, Inc. (OTCQB: NVLX) is an international biotechnology firm focused on developing and preparing to commercialize treatments for cancer, diabetes and other diseases based on the live, therapeutically valuable, encapsulated cells platform. The Company is leveraging its cancer biology and clinical oncology research experience and expertise, particularly for use in oncology treatments, in addition to initiating oncology applications of medical marijuana.
Posted in
News
Posted by
Kenneth L. Waggoner
Its so obvious yet some still don't get it. PMCB is operated the same way as it was when it was Nuvilex and Efood safety. Issue PR's sell shares and pay management. This company has been doing it for 21 years. The only people that have ever made money are the ones trading and that is probably is over also.
As a reminder. PMCB is a stock selling scam whose only accomplishment is enriching the shady management. Shady Kenny 5 years of promising investors trials while selling hundreds of millions of shares all to pay himself and his buddies $MILLIONS$. Read the hype pr's on the PMCB website and then listen to the company conference call and hear all about failure and excuse making. IMHO
Difference is I have been correct. So once more. PMCB is nothing but a share selling company in business only to enrich its shady management. IMHO.
How many times over the past 10+ years do you think you posted the exact same thing? Shady Kenny has nothing left in his bag of deception everything failed and TD2 Bailed.
Name one biotech that has become successful by going to China instead of the US and Europe. China copies technology thy don't make fake biotech's wealthy. If CIAB worked they would have copied it already.
Says a man who is part of a bunch of shell companies in China. Yes Tong is a perfect match for PMCB.
What foundation is going to contribute to the Shady Kenny retirement fund. Really a company supposedly in the biotech business for 5+ years that has released ZERO clinical or pre-clinical data and can't do anything right other then selling shares and overpaying its incompetent management. I am sure they have tried and i am sure they have been told NO F'n Way.
As soon as PMCB releases a study on anything so probably never.
If Austrianova's technology was so groundbreaking why has it been out their for 20 years with no interest? Does anyone really believe that all other companies (except a penny stock natural cure company)looked at the technology and data from two tiny trials and said this is going to be huge but we pass.
The whole concept of CIAB is silly. We have a cellulose membrane with tiny holes filled with cells and how exactly is the chemo going to get into those holes that are also emitting waste get activated and then get released from the membrane thru those tiny holes and in enough qty to destroy a tumor covered in a protective sheath. The natural pressure of a membrane filled with cells is going to be the pressure of waste outward not inward. And this doesn't even consider how fast this would have to happen as the natural rate of blood flow carries the chemo away from the site.
What would you expect! Its all part of the scam buddy system these penny stock companies have. Bring people on that on the surface look legit but a deep dive shows that they are all just associated with other scam companies. Of course most penny stock investors don't do deep dives they rely on hype pr's.
PMCB brought CIAB to TD2 and after experimenting with CIAB informed Shady Kenny he was wasting his time. Trying to con people that TD2 couldn't run a trial of a couple hundred people is just nonsense. Does anyone really believe one of the best CRO's in the USA waited 10 months after the pre-ind to inform PMCB that they couldn't handle a trial that was discussed in that meeting.
Selling General and Administrative Spend (2016) $2,781,221 (2015) $4,207,797 (2014) $8,899,477 yet listed pay for 4 employees only around 700k a year. Where do you think the rest of this money is going? Its not the medical consultants that is in R&D expense. They have no physical location and their shared office space is 33k a year. Where does all of the rest of that money go I wonder......
If PMCB closed the doors today Shady Kenny would still retire a wealthy man. He has made his money and really could care less about shareholders. I don't expect a shareholder update will ever happen again.
A company that has spent $38,000,000 since 2014 and raised its share count by almost 400,000,000 all while accomplishing nothing except loading managements bank accounts is a SCAM plain and simple. A 70 year old lawyer and his shady buddy a CPA running an alleged biotech that has produced no clinical or pre-clinical data in 5 years is not a real company.
IMHO The SEC should be looking into PMCB there are Shady companies and then there are outright SCAM'S and PMCB is a S C A M !
There are so many holes in Shady Kenny's CC that its just one giant hole. And not one excuse Shady boy made can be verified. Why is it that no PR was released to the news wire after the CC summarizing the material events discussed? Such a SCAM.
Ya they are paid for articles by PMCB. Its how they sucker people in.
PMCB has 3 million in cash as of two months ago probably around 2 now unless they are selling tens of millions of more shares.
The company did not even release a PR with all of the material events that have occurred over the past year after the CC. Just a link to the CC on Facebook. That should tell everyone how bad the news was on the CC.
Really the best Doctors in the world? BTW not one doctor actually works for PMCB they all have a full time ++ job and consult with multiple companies. Not one of them are really associated with this do nothing company.